| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 05/24/2012 | WO2012068531A2 Novel compositions and uses of anti-hypertension agents for cancer therapy |
| 05/24/2012 | WO2012068483A1 Preselection of subjects for therapeutic treatment based on hypoxic status |
| 05/24/2012 | WO2012068477A1 Methods and compositions for inhibiting angiogenesis and tumor growth |
| 05/24/2012 | WO2012068470A2 Immune regulatory oligonucleotide (iro) compounds to modulate toll-like receptor based immune response |
| 05/24/2012 | WO2012068456A2 Compositions and methods for treating obesity |
| 05/24/2012 | WO2012068332A2 Methods for treating early stage or mild neurological disorders |
| 05/24/2012 | WO2012068229A1 Compositions and methods for treating alphavirus infection |
| 05/24/2012 | WO2012068148A1 Regimens for treatments using anti-igf antibodies |
| 05/24/2012 | WO2012068098A1 Methods for treating cancer with dll4 antagonists |
| 05/24/2012 | WO2012068077A1 Leishmania canine challenge model by sand fly bites |
| 05/24/2012 | WO2012068073A2 Therapeutic and diagnostic applications targeting tnk-1 |
| 05/24/2012 | WO2012068032A1 Fgfr1 extracellular domain combination therapies |
| 05/24/2012 | WO2012067981A1 Combination therapy for b cell lymphomas |
| 05/24/2012 | WO2012067866A2 Multivalent vaccine for filariasis |
| 05/24/2012 | WO2012067624A1 Immunoglobulin cleavage fragments vaccine compositions |
| 05/24/2012 | WO2012067176A1 Multi-specific antigen-binding molecule having alternative function to function of blood coagulation factor viii |
| 05/24/2012 | WO2012066519A1 Luteinizing-hormone ligand and ligand-gonadotrophin complex |
| 05/24/2012 | WO2012066495A2 T-cell therapy to neurodegenerative diseases |
| 05/24/2012 | WO2012066481A1 New ethiological agent |
| 05/24/2012 | WO2012066420A1 Lipidated polyepitope vaccines |
| 05/24/2012 | WO2012066331A1 Cross protective epitopes of aspergillus fumigatus and candida albicans |
| 05/24/2012 | WO2012066293A1 Therapeutic agent |
| 05/24/2012 | WO2012065997A1 Respiratory syncytial virus vaccine |
| 05/24/2012 | WO2012065286A1 Composition of dna vaccine for preventing and treating hepatitis b |
| 05/24/2012 | WO2012065263A1 Immunogenic compositions |
| 05/24/2012 | WO2012065262A1 Expression, purification and refolding of recombinant chlamydia proteins, compositions and related methods |
| 05/24/2012 | WO2012046006A3 Cutaneous squamous cell carcinoma target sequences |
| 05/24/2012 | WO2012038832A3 Generation of replicating chimeric measles virus - retrovirus particles |
| 05/24/2012 | WO2012023810A3 Pharmaceutical composition for promoting angiogenesis, and method for screening for active substances for promoting angiogenesis |
| 05/24/2012 | WO2012023008A3 Polysaccharide conjugation with detoxified e. coli heat labile enterotoxin (lt) used as vaccine |
| 05/24/2012 | WO2012016173A3 Safe and functional humanized anti beta-amyloid antibody |
| 05/24/2012 | WO2012006490A4 Dual variable domain immunoglobulins and uses thereof |
| 05/24/2012 | WO2011163539A3 nAChRα7 AGONISTS AND nAChRα7 ANTAGONISTS FOR TREATING ULCERATIVE COLITIS (UC) AND CROHN'S DISEASE (CD) |
| 05/24/2012 | WO2011153277A3 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of lysyl-trna synthetases |
| 05/24/2012 | WO2011150281A4 A compositon for neurological or autoimmune diseases |
| 05/24/2012 | US20120130300 Therapeutic Methods Using Controlled Delivery Devices Having Zero Order Kinetics |
| 05/24/2012 | US20120130144 Treatment of lung cancer with a nitrobenzamide compound in combination with a growth factor inhibitor |
| 05/24/2012 | US20120128783 Compositions and methods for delivery of frozen particle adhesives |
| 05/24/2012 | US20120128763 Lubricant for the ocular surface |
| 05/24/2012 | US20120128759 Method to inhibit airway hyperresponsiveness using aerosolized t cell receptor antibodies |
| 05/24/2012 | US20120128758 Formulation for inducing broadly reactive neutralizing anti-hiv antibodies |
| 05/24/2012 | US20120128756 Skin Permeating And Cell Entering (SPACE) Peptides and Methods of Use Thereof |
| 05/24/2012 | US20120128752 Multi-phase microparticles and method of manufacturing multi-phase microparticles |
| 05/24/2012 | US20120128724 Systems and methods for treating human inflammatory and proliferative diseases and wounds, with fatty acid metabolism inhibitors and/or glycolytic inhibitors |
| 05/24/2012 | US20120128722 Novel Monensin Derivatives for the Treatment and Prevention of Protozoal Infections |
| 05/24/2012 | US20120128721 Schistosoma vaccine |
| 05/24/2012 | US20120128720 Mycobacterium mutants for vaccines with improved protective efficacy |
| 05/24/2012 | US20120128719 Streptococcus vaccine compositions and methods of using the same |
| 05/24/2012 | US20120128717 Influenza virus vaccine composition and methods of use |
| 05/24/2012 | US20120128716 Vaccine Compositions |
| 05/24/2012 | US20120128715 Method for stimulating the immune response of newborns |
| 05/24/2012 | US20120128714 Alphavirus Replicon Particles Expressing TRP2 |
| 05/24/2012 | US20120128713 Replication-Defective Flavivirus Vaccine Vectors Against Respiratory Syncytial Virus |
| 05/24/2012 | US20120128712 Vaccine directed against porcine pleuropneumonia and a method to obtain such a vaccine |
| 05/24/2012 | US20120128710 Enhancement of Pathogen-Specific Memory Th17 Cell Responses |
| 05/24/2012 | US20120128709 Expression of recombinant proteins |
| 05/24/2012 | US20120128708 Diagnostic mycobacterium tuberculosis test |
| 05/24/2012 | US20120128707 Streptococcus pneumoniae proteins and nucleic acids |
| 05/24/2012 | US20120128706 Immune adjuvant comprising atp |
| 05/24/2012 | US20120128705 C6orf167 peptides and vaccines containing the same |
| 05/24/2012 | US20120128702 Novel biomarkers for a prediction of the outcome of an immunotherapy against cancer |
| 05/24/2012 | US20120128701 Compositions and methods for the removal of biofilms |
| 05/24/2012 | US20120128700 Constructs for delivery of therapeutic agents to neuronal cells |
| 05/24/2012 | US20120128699 Immune regulatory oligonucleotide (iro) compounds to modulate toll-like receptor based immune response |
| 05/24/2012 | US20120128698 Diagnosis and treatment of autoimmune demyelinating diseases |
| 05/24/2012 | US20120128697 NOTCH Inhibition in the Treatment or Prevention of Atherosclerosis |
| 05/24/2012 | US20120128696 Methods for detecting and inhibiting angiogenesis |
| 05/24/2012 | US20120128695 Teneurin c-terminal associated peptides (tcap) and methods and uses thereof |
| 05/24/2012 | US20120128694 Therapeutic agents for alzheimer's disease and cancer |
| 05/24/2012 | US20120128693 Cadherin-11 inhibitors and methods of use thereof |
| 05/24/2012 | US20120128692 Human cytomegalovirus neutralizing antibodies and use thereof |
| 05/24/2012 | US20120128691 Human cytomegalovirus neutralizing antibodies and use thereof |
| 05/24/2012 | US20120128690 Methods for determining agents that treat or prevent obesity and/or obesity related diseases and methods for treatment therewith |
| 05/24/2012 | US20120128689 Anti-il-23 immunoglobulins |
| 05/24/2012 | US20120128688 Anti-cxcl13 and anti-cxcr5 antibodies for the prevention and treatment of cancer and cancer cell migration |
| 05/24/2012 | US20120128687 Novel antibody formulation |
| 05/24/2012 | US20120128686 Thienopyrimidines for pharmaceutical compositions |
| 05/24/2012 | US20120128685 Use of high-dose oxazaphosphorine drugs in combination with monoclonal antibodies for treating immune disorders |
| 05/24/2012 | US20120128684 Conserved Hemagglutinin Epitope, Antibodies to the Epitope and Methods of Use |
| 05/24/2012 | US20120128683 Autism treatment |
| 05/24/2012 | US20120128682 Apolipoprotein l- i variants and their use |
| 05/24/2012 | US20120128681 Anti-CK8 Antibodies To Be Used For Treating Colorectal Cancers And Identifying Metastatic And/Or Invasive Phenotypes |
| 05/24/2012 | US20120128680 Biomarker antibody and diagnosis device for detecting certain autoimmune diseases |
| 05/24/2012 | US20120128679 Human Antibodies to the Glucagon Receptor |
| 05/24/2012 | US20120128678 Diagnosis and treatment of cancer using anti-tmprss11e antibody |
| 05/24/2012 | US20120128677 Pancreatic cancer targets and uses thereof |
| 05/24/2012 | US20120128676 Muc1 antibodies |
| 05/24/2012 | US20120128675 Anti-fgf19 antibodies and methods using same |
| 05/24/2012 | US20120128674 C3b antibodies and methods for the prevention and treatment of complement-associated disorders |
| 05/24/2012 | US20120128673 Modulation of pilr receptors to treat microbial infections |
| 05/24/2012 | US20120128672 Treatment of cancer with elevated dosages of soluble fgfr1 fusion proteins |
| 05/24/2012 | US20120128671 Neutralizing molecules to influenza viruses |
| 05/24/2012 | US20120128670 mTOR INHIBITOR AND ANGIOGENESIS INHIBITOR COMBINATION THERAPY |
| 05/24/2012 | US20120128669 Monovalent, bivalent and trivalent anti human respiratory syncytial virus (hrsv) nanobody constructs for the prevention and/or treatment of respiratory tract infections |
| 05/24/2012 | US20120128668 Method of promoting bone growth by an anti-activin antibody |
| 05/24/2012 | US20120128667 Pentamidine combinations for treating cancer |
| 05/24/2012 | US20120128666 Methods of increasing neuronal differentiation using antibodies to lysophosphatidic acid |
| 05/24/2012 | US20120128665 Preselection of subjects for therapeutic treatment based on hypoxic status |
| 05/24/2012 | US20120128664 Glycosylated antibodies |
| 05/24/2012 | US20120128663 Fc VARIANTS THAT EXTEND ANTIBODY HALF-LIFE |